funding bodies had no role in the design or undertaking of the study.
48

INTRODUCTION 137
Acute febrile illness is among the most common of all presentations to the children's 138 Emergency Department (ED). 1 In this context, the probability of serious bacterial infection 139 (SBI) is estimated to be 7% -predominantly lower respiratory or urinary tract infection. 2
140
The prompt recognition of SBI is fundamental to effective management. Children with 141 meningococcal disease are frequently missed at initial presentation, 3 and delayed recognition 142 increases mortality. 4, 5 Though rates of invasive infection have declined with the introduction 143 of conjugate vaccines, 6-8 SBI remains an important contributor to childhood morbidity and 144 mortality. 9
145
In the UK, as rates of invasive infections have declined, the number of children admitted to 146 hospital has increased. 10 The greatest increase is in young children with uncomplicated 147 admissions for acute infections. 11 Supporting clinicians to rule out SBI may reduce 148 unnecessary hospital admissions in children. 12 
149
A number of studies have reported the diagnostic accuracy of clinical 13 and laboratory 14 150 variables in febrile children. More recently, risk prediction models combining clinical 151 variables have been evaluated, 2, 15 and in one the addition of CRP improved diagnostic 152 accuracy. 16 We ourselves have previously reported the combined performance of guidelines. 19, 20 170 Participants 171 Children less than 16 years of age with fever (>38°C) or history of fever were eligible if they 172 required blood tests as part of clinical management. Children with primary immunodeficiency 173 were excluded. Using prior estimates of sensitivity and specificity of 65% and 90% 174 respectively, and a rate of SBI of 15%, a sample size of 2300 was proposed. For skin and soft 175 tissue infections, the reference standard for SBI was that children were deemed by the clinical 176 team to require intravenous antibiotics. As the outcome diagnosis was solely based upon a 177 clinical decision, and as this was true of all such cases, these children (n=82) were excluded 178 ( Figure 1 ).
179
Patient involvement 180
The GenerationR Young Person's Advisory Group (www.generationr.org.uk and 2, Varicella Zoster and Enterovirus) samples at the regional laboratory in Manchester. Table 2 ). 14, 15, 24, 25 Using these pre-defined criteria, a paediatric research 218 fellow and a paediatric infectious disease consultant independently attributed outcome 219 diagnosis. In the case of disagreement, a second paediatric infectious disease consultant 220 determined final outcome. Children who failed to meet the pre-defined criteria for SBI were 221 considered to have 'No SBI'. Subjects were followed up to 28 days to reduce 222 misclassification.
223
Statistical methods
224
Analysis was undertaken in R, version 3.0.1. 26 Missing data were handled by ten-fold 225 multiple imputation using fully conditional specification implemented by the MICE terms were explored, including interactions between age, heart rate and respiratory rate. A 238 multivariable model was derived using a forwards stepwise method. Improvements in model 239 fit were tested by means of a likelihood ratio test (α=0.05) and variables associated with a 240 significant improvement were retained. Having identified a parsimonious model for SBI, 241 these variables were then included in a multinomial regression model for the categorical 242 outcomes "pneumonia", "other SBI", and "no SBI". In the absence of established methods to report classification in multinomial risk prediction 264 models, we compared crude classification (that is, the most likely diagnosis predicted by the 265 multinomial models) in the updated and extended models. To investigate potential clinical 266 utility, we estimated the ability of the models to 'rule-out' SBI (predictions for both 267 categories of SBI <5%), or to 'rule-in' SBI (prediction of either category >20%). These Children's ED with fever. Of these, 1872 were eligible for inclusion, and 1101 recruited to 278 the study (Figure 1 ). Median age was 2.4 years (IQR 0.9-5.7 years), and 55% were boys.
279
Approximately one third of children had significant comorbidities (Table 1) . 264 children 280 (24.0%) were diagnosed with SBI (supplementary figure 1).
281
The probability of pneumonia and other SBIs increased linearly with heart rate, respiratory predicted risks and observed outcomes were highly correlated (Figure 3) .
304
Observing the correlation between predicted probabilities and observed outcomes in the 305 poorly calibrated model, we updated the model by re-estimating the individual co-efficients. 
312
The performance characteristics of the updated and extended models are summarised in Table   313 2. At a low-risk threshold of 5%, the extended pneumonia model had a sensitivity of 92% 314 (95%CI 85 to 96%) and negative likelihood ratio (NLR) of 0.12 (0.06 to 0.23). For other 315 SBIs, model sensitivity was 92% (86 to 95%), and NLR 0.21 (0.12 to 0.35). At a high-risk 316 threshold (>20%), specificity was 89% (95%CI 87 to 91%) for pneumonia, with a positive 317 likelihood ratio (PLR) of 6.69 (5.30 to 8.44), and 86% (83 to 88%), PLR of 4.96 (4.07 to 318 6.03) for other SBIs. Table 7) . Using the extended model, SBI was correctly 'ruled out' in 31 323 additional children (3.7%, 95%CI -1.0 to 8.4%) and there were five fewer potentially missed 324 SBI diagnoses (14/264 v 19/264, 1.8% reduction, 95%CI -2.6 to 6.4%, Table 3 ). Strengths: 338 We present data on multiple biomarkers of SBI in more than 1000 children. We have 339 evaluated children irrespective of age, past medical history or clinical syndrome, and 340 obtained comparable discrimination to other studies with more restrictive inclusion criteria. 
358
Diagnostic studies with imperfect reference standards require a pragmatic approach to 359 determine outcomes. An established approach to this is to use pre-defined composite 360 reference standards as we have done. The universal application of respiratory viral assays 361 may have yielded additional evidence upon which to base classification but such testing was 362 undertaken at the discretion of the clinical team, and not applied systematically. Our use of a 363 radiological diagnosis of 'pneumonia', despite its limitations, is common in this setting. 15, 33 
364
We included a category of 'probable SBI' to account for the lack of sensitivity of 365 conventional diagnostic testing in children. This category accounted for only a small number 366 of cases (8), and was defined in advance. By establishing clear criteria for each outcome 367 diagnosis, we have sought to minimise verification bias. 368 We studied children already considered at risk of SBI, in whom the clinical team had initiated 369 further investigation. This unmeasured risk evaluation limits the external validity of our 370 findings. The proportion of SBI (24%) is significantly higher than that observed in all febrile 371 children in the ED and we agree with previous authors who have stressed the importance of 
378
Comparison with published studies 379 Our finding that clinical variables such as hypoxia, abnormal respiratory findings, irritability 380 and dehydration increase the probability of SBI is consistent with similar studies. 2, 13, 16 We 381 failed to demonstrate the value of more subjective assessments, such as 'ill appearance', and 382 'parental concern', though for each there was a significant problem of missing data.
383
Next steps: 384 Our results support a growing body of research to suggest that risk prediction models 385 improve the identification of SBI in the children's ED. Such models have yet to translate into 386 improved clinical decision-making. Two recent impact studies challenge the assumption that 387 accurate risk prediction will necessarily improve decision-making. In the first, the use of the 388 'Lab Score' -a decision rule combining CRP, PCT and urinalysis -failed to reduce antibiotic 389 prescriptions in children in the ED. 34 A second evaluated the use of the Nijman risk 390 prediction model to guide decisions, and no impact on antibiotic prescribing, or hospital 391 admission was observed 35 .
392
Future impact studies need to evaluate the behaviours associated with decision-making. This 393 has been of considerable importance in evaluating interventions to rationalise antibiotic 394 prescribing 36 . In order to translate estimates of risk into safe clinical decisions and improve 395 the management of children in the ED, it will be necessary to involve clinicians and families .
396
The risk thresholds we have proposed are not yet established in the context of SBI in the 397 children's ED, and more work is necessary to determine whether they, and the clinical 398 decisions they guide, are appropriate. No SBI  269  355  76  137  300  352  74  111  837  Pneumonia  6  19  70  13  5  16  71  16  108  Other SBI  13  29  7  107  9  33  7  107  156  Total  288  403  153  257  314  401  152  234  1101  Table 3 : Outcomes according to risk classification for the updated and extended models. SBI was considered 'ruled-out' if the predicted probabilities of both pneumonia ("Pneu") and other SBI ("Other") were <5%, while SBI was considered 'ruled-in' if the probability of either outcome was >20%. All other subjects were considered to be at intermediate risk. 
Pneumonia
Respiratory symptoms and signs and focal consolidation on X-ray reported by a paediatric radiologist.
Other SBI
Bacteraemia Identification of a significant bacterial pathogen in blood using culture or molecular methods.
Urinary tract infection
Growth of a single bacterial urinary tract pathogen at ≥10 5 colonyforming units/ml in a normally sterile urine sample in the context of clinical signs of systemic involvement.
Meningitis
Identification of a bacterial pathogen in CSF using culture or molecular methods, or clinical meningitis plus a cerebrospinal fluid polymorphonuclear leucocytosis in the absence of an alternative aetiological diagnosis. Osteomyelitis Clinical signs, and radiological confirmation or identification of a pathogen in the bloodstream.
Septic arthritis
Isolation of a bacterial pathogen from a joint.
Probable SBI Prolonged admission, and administration of intravenous antibiotics beyond 72h despite negative culture results. 
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